Skip to content
VisionGate LogoVisionGate LogoVisionGate Logo
  • Home
  • About
    • Our Team
  • Our Technology
    • Non-Intrusive Testing
    • Patented Cell-CT Imaging
    • AI Powered Detection
  • Blog
    • News
    • Patents
    • Publications
    • Research
  • Contact

Blog

  • NewsFPO
  • Patents
  • Publications
  • ResearchFPO
  • November 12, 2020

    Patients FAQ’s

    More Information

    News

  • August 25, 2020

    #10,753,857:
    APPARATUS AND METHOD FOR MEASURING MICROSCOPIC OBJECT VELOCITIES IN FLOW

    More Information

    Patents

  • September 28, 2018

    VisionGate Presents at the 2018 conference of the American Thoracic Society: Positive Rate Of The Lung Cell Evaluation (LuCED) Test For Patients With Chronic Obstructive Pulmonary Disease (COPD)

    More Information

    Research

  • September 28, 2018

    VisionGate Presents at the World Conference on Lung Cancer for 2018 in Toronto: Malignancy Associated Change and The LuCED® Test for Detection of Early Stage Lung Cancer

    More Information

    Research

  • April 5, 2018

    VisionGate is Leveraging the Cell-CT™ Platform to Expand Cancer Diagnostics Services

    More Information

    News

  • October 16, 2017

    VisionGate Presents at the World Conference on Lung Cancer for 2017 in Tokyo: Effect of Tumor Size on the Sensitivity of the Non-Invasive LuCED® Test for Lung Cancer

    More Information

    Research

  • October 16, 2017

    VisionGate Presents at the World Conference on Lung Cancer for 2017 in Tokyo: Morphometric Genotyping Identifies Lung Cancer Cells Harboring Target Mutations; Cell-CT® Platform Detects Gene Abnormalities

    More Information

    Research

  • October 16, 2017

    VisionGate Presents at the World Conference on Lung Cancer for 2017 in Tokyo: Cell-CT® Differential Detection of Dysplastic Bronchial Epithelial Cells from Patient Explants

    More Information

    Research

  • March 14, 2017

    #9,594,072:
    SYSTEM AND METHOD FOR DETERMINING CELL ADEQUACY IN A CYTOLOGICAL ANALYSIS SYSTEM

    More Information

    Patents

  • January 5, 2017

    VisionGate® to attend JP Morgan Healthcare Conference

    More Information

    News

Previous234Next
visiongate logo retina logo

Follow Us

x icon
  • Home
  • About
  • Our Technology
Contact

© Copyright 2005 – 2025 | VisionGate, Inc | Milwaukee Web Design by Flipeleven | All Rights Reserved

3 Questions to Assess Your Risk

 Early detection of lung cancer is important to keeping you healthy and living your life to the fullest.

Has a family member had Lung Cancer? *
Have you smoked or been exposed to secondhand smoke? *

If you are over the age of 60 or answer "Yes" to any of the questions above, you may be at an increased risk.

This test is not a diagnosis but can help you recognize factors that may increase your risk of developing lung cancer. Next, You can subscribe to learn more from VisionGate. Then, you'll be redirected to a page of resources that can aid you in discussions with your doctor, or click here to access the page directly.

If you are above the age of 50 and answered "Yes" to any of the questions, you may be at an increased risk of developing lung cancer, but this is not a diagnosis. Use the link below to download resources that can help you talk to your doctor. Click Here to Download
We're sorry! There was an error submitting the test. Please try again later.

*No personal information is collected or saved through this form without your consent. Only your email and name will be saved if you opt-in.

visiongate logo
Contact
  • Home
  • About
  • Our Technology

© Copyright 2005 – 2025 | VisionGate, Inc | Milwaukee Web Design by Flipeleven | All Rights Reserved

Page load link
Go to Top